Transforming growth factor-β1 gene activation and growth of smooth muscle from hypertensive rats

Hypertension

Volumn 23, Issue 5, 1994, Pages 593-599

  Agrotis, Alex ^a,b   Saltis, John ^a   Bobik, Alex ^a  

^a ALFRED HOSPITAL   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

muscle, smooth, vascular; proliferation; protein tyrosine kinase; rats, inbred SHR; transforming growth factor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CELL RECEPTOR; EPIDERMAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; PROTEIN TYROSINE KINASE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL GROWTH; DRUG POTENTIATION; GENE ACTIVATION; GENE EXPRESSION; GENE INDUCTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE;

EID: 0028175959     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.23.5.593     Document Type: Article

References (39)

1. Folkow B. Physiological aspects of primary hypertension. Physiol Rev. 1982;62:347-504.
2. Mulvany MJ, Hansen PK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res. 1978;43:854-864.
3. Scott-Burden T, Resink TJ, Baur U, Bürgin M, Buhler FR. Epidermal growth factor responsiveness in smooth muscle cells from hypertensive and normotensive rats. Hypertension. 1989; 13:295-304.
4. Hadrava V, Tremblay J, Hamet P. Abnormalities in growth characteristics of aortic smooth muscle cells in spontaneously hypertensive rats. Hypertension. 1989;13:589-597.
5. Hamada M, Nishio I, Baba A, Fukuda K, Takeda J, Ura M, Hano T, Kuchii M, Masuyama Y. Enhanced DNA synthesis of cultured vascular smooth muscle cells from spontaneously hypertensive rats: difference of response to growth factor, intracellular free calcium concentration and DNA synthesizing cell cycle. Atherosclerosis. 1990;81:191-198.
6. Saltis J, Bobik A. Vascular smooth muscle growth in genetic hypertension: evidence for multiple abnormalities in growth regulatory pathways. J Hypertens. 1992;10:635-643.
7. Massagué J. The transforming growth factor-β family. Annu Rev Cell Biol. 1990;6:597-641.
8. Roberts AB, Sporn MB. The transforming growth factor-betas. In: Sporn M, Roberts AB, eds. Peptide Growth Factors and Their Receptors. Heidelberg, Germany: Springer-Verlag; 1991:419-472.
9. Owens GK, Geisterfer AAT, Yang YW-H, Komoriya A. Transforming growth factors-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J Cell Biol. 1988;107:771-780.
10. Goodman LV, Majack RA. Vascular smooth muscle cells express distinct transforming growth factor-β receptor phenotypes as a function of cell density in culture. J Biol Chem. 1989;264:5241-5244.
11. Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R. TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell. 1990;63: 515-524.
12. Majack RA. Beta-type transforming growth factor specifies organizational behaviour in vascular smooth muscle cell cultures. J Cell Biol. 1987;105:465-471.
13. Majack RA, Majesky MW, Goodman LV. Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-β. J Cell Biol. 1990;111:239-247.
14. Sarzani R, Brecher P, Chobanian AV. Growth factor expression in aorta of normotensive and hypertensive rats. J Clin Invest. 1989;83: 1404-1408.
15. Sarzani R, Arnaldi G, Takasaki I, Brecher P, Chobanian AV. Effects of hypertension and aging on platelet-derived growth factor and platelet-derived growth factor receptor expression in rat aorta and heart. Hypertension. 1991;18(suppl III):III-93-III-99.
16. Hamet P, Hadrava V, Kruppa U, Tremblay J. Transforming growth factor-β1 expression and effect in aortic smooth muscle cells from spontaneously hypertensive rats. Hypertension. 1991;17: 896-901.
17. Fukuda N, Tremblay J, Hamet P. Participation of proteolysis and transforming growth factor-β1 activation in growth of cultured vascular smooth muscle cells from spontaneously hypertensive rats. Gen Hypertens. 1992;218:227-229.
18. Saltis J, Agrotis A, Bobik A. TGF-β1 potentiates growth factor-stimulated proliferation of vascular smooth muscle cells in genetic hypertension. Am J Physiol. 1992;263:C420-C428.
19. Qian SW, Kondaiah P, Roberts AB, Sporn MB. cDNA cloning by PCR of rat transforming growth factor-β1. Nucleic Acids Res. 1990; 18:3059.
20. Little PJ, Cragoe EJ, Bobik A. Na/H exchange is a major pathway for Na influx in rat vascular smooth muscle. Am J Physiol. 1986; 251:C707-C712.
21. Black MJ, Adams MA, Bobik A, Campbell JH, Campbell GR. Effect of enalapril on aortic smooth muscle cell polyploidy in the spontaneously hypertensive rat. J Hypertens. 1989;7:997-1003.
22. Saltis J, Agrotis A, Bobik A. Differences in growth characteristics of vascular smooth muscle from spontaneously hypertensive and Wistar-Kyoto rats are growth factor dependent. J Hypertens. 1993; 11:629-637.
23. Massagué J. Subunit structure of a high-affinity receptor for type β-transforming growth factor: evidence for a disulfide-linked glycosylated receptor complex. J Biol Chem. 1985;260:7059-7066.
24. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
25. Feinberg AP, Vogelstein B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983;132:6-13.
26. Snedecor GW, Cochran WG. Statistical Methods. 7th ed. Ames, Iowa: Iowa State University Press; 1980.
27. Van Obberghen-Schilling E, Roche NS, Flanders KC, Sporn MB, Roberts AB. Transforming growth factor β1 positively regulates its own expression in normal and transformed cells. J Biol Chem. 1988;263:7741-7746.
28. Kim S-J, Jeang K-T, Glick AB, Sporn MB, Roberts AB. Promoter sequences of the human transforming growth factor-β1 gene responsive to transforming growth factor-β1 autoinduction. J Biol Chem. 1989;264:7041-7045.
29. Kim S-J, Denhez F, Kim KY, Holt JT, Sporn MB, Roberts AB. Activation of the second promoter of the transforming growth factor-β1 gene by transforming growth factor-β1 and phorbol ester occurs through the same target sequences. J Biol Chem. 1989;264: 19373-19378.
30. Boyd FT, Massagué J. Transforming growth factor-β inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor. J Biol Chem. 1989;264:2272-2278.
31. Massagué J. Receptors for the TGF-β family. Cell. 1992;69: 1067-1070.
32. Laiho M, Weis FMB, Boyd FT, Ignotz RA, Massagué J. Responsiveness to transforming growth factor-β (TGF-β) restored by genetic complementation between cells defective in TGF-β receptors I and II. J Biol Chem. 1991;266:9108-9112.
33. DeCaprio JA, Ludlow JW, Lynch D, Furukawa Y, Griffin J, Piwnica-Worms WH, Huang C-M, Livingston DM. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell. 1989;58:1085-1095.
34. Nurse P. Universal control mechanism regulating onset of M-phase. Nature. 1990;344:503-508.
35. Clark CJ, Milligan G, McLellan AR, Connel JMC. Guanine nucleotide regulatory protein levels and function in spontaneously hypertensive rat vascular smooth muscle cells. Biochim Biophys Acta. 1992;1136:290-296.
36. 1. J Biol Chem. 1993;268:19851-19857.
37. Clowes AW, Clowes MM, Au YPT, Reidy MA, Belin D. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res. 1990;67:61-67.
38. Roswit WT, Rifas L, Gast MJ, Welgus HG, Jeffrey JJ. Purification and characterization of human myometrial smooth muscle collagenase. Arch Biochem Biophys. 1988;262:67-75.
39. Lyons RM, Keski-Oja J, Moses HL. Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned medium. J Cell Biol. 1988;106:1659-1665.